POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 90 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $502,887 | +34.9% | 211,297 | -0.2% | 0.00% | – |
| Q2 2023 | $372,650 | +148.0% | 211,733 | +334.0% | 0.00% | – |
| Q1 2023 | $150,252 | -41.9% | 48,783 | 0.0% | 0.00% | – |
| Q4 2022 | $258,550 | +47.7% | 48,783 | -1.4% | 0.00% | – |
| Q3 2022 | $175,000 | +288.9% | 49,468 | +181.7% | 0.00% | – |
| Q2 2022 | $45,000 | -90.2% | 17,558 | -82.8% | 0.00% | – |
| Q1 2022 | $457,000 | -35.4% | 102,049 | -1.7% | 0.00% | – |
| Q4 2021 | $707,000 | -4.3% | 103,839 | +2.4% | 0.00% | – |
| Q3 2021 | $739,000 | -11.0% | 101,388 | +22.3% | 0.00% | – |
| Q2 2021 | $830,000 | +37.6% | 82,900 | +31.4% | 0.00% | – |
| Q1 2021 | $603,000 | +86.1% | 63,100 | +113.3% | 0.00% | – |
| Q4 2020 | $324,000 | +57.3% | 29,581 | +27.0% | 0.00% | – |
| Q3 2020 | $206,000 | – | 23,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,945,948 | $5,184,868 | 1.60% |
| Aisling Capital Management LP | 1,043,267 | $1,836,150 | 0.90% |
| Knott David M Jr | 140,921 | $248 | 0.10% |
| XTX Topco Ltd | 233,493 | $410,948 | 0.07% |
| Pentwater Capital Management LP | 5,975,000 | $10,516,000 | 0.07% |
| Atom Investors LP | 49,413 | $86,967 | 0.03% |
| EcoR1 Capital, LLC | 676,296 | $1,190,281 | 0.03% |
| Forefront Analytics, LLC | 26,619 | $46,850 | 0.03% |
| FNY Investment Advisers, LLC | 11,500 | $20 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 80,979 | $142,523 | 0.02% |